Index Performance
Overview
Description
The healthcare services industry in the U.S. is a robust and dynamic sector, underpinned by the increasing demand for medical services due to demographic shifts such as an aging population, advancements in medical treatments, and a heightened focus on health and wellness precipitated by public health challenges like the COVID-19 pandemic. The growth is also driven by innovation in healthcare technologies and services, such as telemedicine, as well as regulatory changes and governmental policies which influence reimbursement rates and coverage. With the integration of IT in healthcare, the emphasis on cost reduction and outcome improvement, alongside rising insurance coverage, the sector is poised for upward growth. However, it is also susceptible to policy changes, which adds a level of uncertainty to its long-term prospects. Investing within the healthcare services industry can be varied with several subcategories of interest under the given criteria. [[Integrated Healthcare Services]] are businesses that offer a spectrum of services from primary care to specialized surgeries, optimizing coordinated care and potentially offering significant efficiency. [[Healthcare Technology and Data Analytics]] signifies companies that focus on the integration of IT to improve patient care, enhance data management, and support remote healthcare services, which is particularly relevant in an era of increased telemedicine utilization. [[Managed Healthcare Providers]] describes organizations that arrange for the delivery of healthcare services to patients, attempting to reduce healthcare costs while improving quality of care. [[Pharmaceutical Services and Distribution]] encompasses companies involved in the wholesale distribution of pharmaceuticals and health products as well as the provision of value-added services to the healthcare sector. [[Medical Supplies and Devices]] covers firms specializing in the manufacture and supply of medical equipment, which have found increasing demands following global health crises, technological improvements, and the trend of surgeries moving towards outpatient settings. Each of these subcategories have distinct growth drivers and risks, and demand a thorough analysis of financial health, market position, regulatory pressures, and technological adaptability to determine the strongest investment candidates. This index was generated with help from Thematic Assist.
- TickerHCAP
- Inception Date12/03/2023
- WeightingEqual
- # of holdings67
What's inside?
Sectors
- Health Technology58.39%
- Technology Services10.28%
- Health Services5.97%
- Producer Manufacturing4.49%
- Distribution Services4.46%
- Commercial Services3.01%
- Electronic Technology3.00%
- Retail Trade2.99%
- Process Industries2.98%
- Finance2.96%
- Industrial Services1.46%
Holdings
All holdings as of December 27, 2024
Biogen, Inc. (BIIB) | 1.54% | $22.05B | -2.44% | 65.42% | 3.61 |
Teva Pharmaceutical Industries Ltd. (TEVA) | 1.53% | $25.37B | 13.40% | 49.71% | 2.18 |
Neurocrine Biosciences, Inc. (NBIX) | 1.53% | $14.12B | 24.72% | 97.81% | 4.94 |
Vertex Pharmaceuticals, Inc. (VRTX) | 1.53% | $105.27B | 11.86% | 85.85% | 10.98 |
ICON plc (ICLR) | 1.52% | $17.53B | -1.22% | 24.55% | 3.23 |
Sony Group Corp. (SONY) | 1.52% | $132.26B | -0.50% | 34.15% | 1.52 |
Eli Lilly & Co. (LLY) | 1.52% | $743.48B | 20.43% | 81.02% | 20.30 |
Intuitive Surgical, Inc. (ISRG) | 1.52% | $190.51B | 16.88% | 67.41% | 22.12 |
Boston Scientific Corp. (BSX) | 1.52% | $133.62B | 19.34% | 62.91% | 8.40 |
BioMarin Pharmaceutical, Inc. (BMRN) | 1.51% | $12.75B | 26.69% | 73.94% | 4.93 |
Merck & Co., Inc. (MRK) | 1.51% | $252.20B | 4.42% | 73.43% | 4.96 |
Gilead Sciences, Inc. (GILD) | 1.51% | $117.29B | 7.05% | 79.10% | 4.30 |
Regeneron Pharmaceuticals, Inc. (REGN) | 1.51% | $78.29B | 10.65% | 83.53% | 8.31 |
AbbVie, Inc. (ABBV) | 1.51% | $314.57B | 3.83% | 71.00% | 7.45 |
Hologic, Inc. (HOLX) | 1.51% | $16.48B | -0.00% | 55.52% | 4.84 |
Edwards Lifesciences Corp. (EW) | 1.50% | $44.62B | -8.54% | 79.33% | 6.09 |
IQVIA Holdings, Inc. (IQV) | 1.50% | $36.19B | 4.06% | 28.18% | 3.63 |
Pfizer Inc. (PFE) | 1.50% | $150.86B | 33.78% | 60.85% | 3.73 |
Avantor, Inc. (AVTR) | 1.50% | $14.57B | -0.34% | 32.92% | 3.27 |
Laboratory Corp. of America Holdings (LH) | 1.50% | $19.29B | 7.37% | 25.62% | 1.97 |
Agilent Technologies, Inc. (A) | 1.50% | $38.71B | -4.73% | 54.67% | 6.17 |
GE Healthcare Technologies, Inc. (GEHC) | 1.50% | $36.33B | 0.85% | 40.84% | 2.58 |
Teleflex, Inc. (TFX) | 1.50% | $8.34B | 2.41% | 56.28% | 4.37 |
Walgreens Boots Alliance, Inc. (WBA) | 1.50% | $8.31B | 6.17% | 16.30% | 0.27 |
Cardinal Health, Inc. (CAH) | 1.50% | $28.83B | -4.54% | 3.51% | 0.13 |
Stryker Corp. (SYK) | 1.50% | $139.95B | 11.92% | 61.76% | 6.85 |
Abbott Laboratories (ABT) | 1.50% | $199.44B | 4.85% | 51.02% | 5.01 |
IDEXX Laboratories, Inc. (IDXX) | 1.50% | $33.98B | 6.56% | 61.05% | 11.09 |
Jabil, Inc. (JBL) | 1.50% | $16.30B | -16.61% | 8.48% | 0.61 |
Bristol Myers Squibb Co. (BMY) | 1.50% | $116.99B | 8.44% | 55.64% | 3.13 |
Xylem, Inc. (XYL) | 1.50% | $28.55B | 1.30% | 37.28% | 4.04 |
Carrier Global Corp. (CARR) | 1.50% | $61.82B | 4.41% | 28.28% | 3.53 |
Incyte Corp. (INCY) | 1.50% | $13.34B | 23.81% | 91.00% | 2.75 |
West Pharmaceutical Services, Inc. (WST) | 1.50% | $24.13B | -0.08% | 35.51% | 7.60 |
Johnson & Johnson (JNJ) | 1.49% | $349.23B | 5.27% | 69.19% | 4.64 |
Thermo Fisher Scientific, Inc. (TMO) | 1.49% | $201.22B | 0.23% | 40.87% | 6.25 |
SS&C Technologies Holdings, Inc. (SSNC) | 1.49% | $18.85B | 7.31% | 48.04% | 4.16 |
CVS Health Corp. (CVS) | 1.49% | $55.99B | 6.12% | 13.14% | 0.41 |
DexCom, Inc. (DXCM) | 1.49% | $31.34B | 1.97% | 59.73% | 6.98 |
STERIS Plc (Ireland) (STE) | 1.49% | $20.53B | -1.00% | 43.76% | 4.85 |
Ventas, Inc. (VTR) | 1.49% | $25.38B | 7.52% | 18.96% | 8.35 |
Charles River Laboratories International, Inc. (CRL) | 1.49% | $9.52B | -1.64% | 33.21% | 3.16 |
Align Technology, Inc. (ALGN) | 1.49% | $15.78B | 1.84% | 70.10% | 4.57 |
United Therapeutics Corp. (UTHR) | 1.49% | $16.07B | 22.89% | 88.90% | 5.23 |
Cognizant Technology Solutions Corp. (CTSH) | 1.49% | $39.27B | 3.00% | 31.70% | 1.96 |
HCA Healthcare, Inc. (HCA) | 1.48% | $76.63B | 7.86% | 13.78% | 2.16 |
Leidos Holdings, Inc. (LDOS) | 1.48% | $19.28B | 6.86% | 18.19% | 1.57 |
Ecolab, Inc. (ECL) | 1.48% | $67.32B | 1.02% | 43.40% | 5.11 |
Zimmer Biomet Holdings, Inc. (ZBH) | 1.48% | $21.28B | 4.03% | 64.58% | 3.66 |
Paycom Software, Inc. (PAYC) | 1.48% | $11.55B | 11.23% | 72.31% | 4.98 |
Amgen, Inc. (AMGN) | 1.48% | $141.18B | 23.11% | 60.87% | 6.99 |
Roper Technologies, Inc. (ROP) | 1.48% | $56.18B | 12.87% | 69.23% | 10.07 |
Quest Diagnostics, Inc. (DGX) | 1.48% | $17.04B | 8.41% | 31.51% | 2.50 |
Viatris, Inc. (VTRS) | 1.48% | $14.90B | -4.30% | 41.80% | 1.86 |
Cencora, Inc. (COR) | 1.48% | $43.86B | 12.12% | 2.96% | 0.16 |
Medtronic Plc (MDT) | 1.48% | $103.53B | 5.25% | 59.91% | 4.16 |
McKesson Corp. (MCK) | 1.48% | $73.20B | 21.29% | 3.36% | 0.21 |
Insulet Corp. (PODD) | 1.48% | $18.60B | 25.70% | 70.12% | 8.93 |
Alexandria Real Estate Equities, Inc. (ARE) | 1.47% | $17.19B | 10.90% | 33.39% | 12.30 |
Baxter International, Inc. (BAX) | 1.47% | $14.91B | -27.21% | 36.31% | 2.24 |
Quanta Services, Inc. (PWR) | 1.46% | $47.70B | 15.52% | 13.89% | 2.15 |
ResMed, Inc. (RMD) | 1.46% | $34.23B | 11.08% | 57.64% | 7.58 |
Okta, Inc. (OKTA) | 1.46% | $13.99B | 13.87% | 76.39% | 4.33 |
Tencent Holdings Ltd. (TCEHY) | 1.46% | $491.42B | 9.32% | 51.53% | 6.10 |
Alnylam Pharmaceuticals, Inc. (ALNY) | 1.44% | $30.69B | -33.26% | 82.85% | 16.86 |
EXACT Sciences Corp. (EXAS) | 1.44% | $10.65B | 12.78% | 68.88% | 5.33 |
Veeva Systems, Inc. (VEEV) | 1.42% | $34.74B | 13.41% | 75.06% | 11.09 |